We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+3.87%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$4.81B
AUM Growth
-$531M
Cap. Flow
-$1.18B
Cap. Flow %
-24.44%
Top 10 Hldgs %
18.16%
Holding
673
New
167
Increased
91
Reduced
97
Closed
256

Top Buys

Rank Stock Value
1
CL icon
Colgate-Palmolive
CL
+$59.4M
2
ONXX
ONYX PHARMACEUTICALS INC
ONXX
+$56.3M
3
SPG icon
Simon Property Group
SPG
+$52M
4
TSM icon
TSMC
TSM
+$45.4M
5
M icon
Macy's
M
+$44.3M

Sector Composition

Rank Sector Weight
1 Real Estate 14.75%
2 Consumer Staples 11.78%
3 Consumer Discretionary 6.16%
4 Financials 6.01%
5 Industrials 5.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FRME icon
201
First Merchants
FRME
$2.69B
$3.5M 0.07%
202,246
-107,741
-35% -$1.93M
PLD icon
202
Prologis
PLD
$130B
$3.48M 0.07%
+92,397
New +$3.48M
MON
203
DELISTED
Monsanto Co
MON
$3.47M 0.07%
33,243
-140,462
-81% -$14.1M
X
204
DELISTED
US Steel
X
$3.42M 0.07%
+166,222
New +$3.13M
RDN icon
205
Radian Group
RDN
$4.82B
$3.41M 0.07%
+245,000
New +$3.27M
CHMT
206
DELISTED
Chemtura Corporation
CHMT
$3.39M 0.07%
+147,288
New +$3.33M
CAM
207
DELISTED
CAMERON INTERNATIONAL CORPORATION
CAM
$3.38M 0.07%
+57,906
New +$3.45M
AAP icon
208
Advance Auto Parts
AAP
$3.49B
$3.28M 0.07%
39,685
-589,067
-94% -$48.2M
SNDA icon
209
Sonida Senior Living
SNDA
$1.91B
$3.15M 0.07%
9,914
-2,010
-17% -$681K
PARA
210
DELISTED
Paramount Global Class B
PARA
$3.13M 0.07%
+56,804
New +$3.02M
NRF
211
DELISTED
NorthStar Realty Finance Corp.
NRF
$3.04M 0.06%
166,921
-311,302
-65% -$5.67M
TRNO icon
212
Terreno Realty
TRNO
$7.2B
$2.98M 0.06%
168,000
+69,613
+71% +$1.26M
UIL
213
DELISTED
UIL HOLDINGS
UIL
$2.79M 0.06%
+75,000
New +$2.9M
DIS icon
214
Walt Disney
DIS
$182B
$2.75M 0.06%
42,597
-74,401
-64% -$4.77M
APD icon
215
Air Products & Chemicals
APD
$66.8B
$2.68M 0.06%
+27,159
New +$2.58M
NUE icon
216
Nucor
NUE
$61.9B
$2.63M 0.05%
+53,595
New +$2.51M
ALJ
217
DELISTED
Alon USA Energy Inc
ALJ
$2.54M 0.05%
+248,500
New +$3.07M
NSC icon
218
Norfolk Southern
NSC
$76.9B
$2.52M 0.05%
32,558
-10,264
-24% -$769K
FNFG
219
DELISTED
FIRST NIAGARA FINANCIAL GROUP INC
FNFG
$2.5M 0.05%
+241,241
New +$2.51M
EVR icon
220
Evercore
EVR
$12B
$2.48M 0.05%
50,390
-182,253
-78% -$8.39M
CBL
221
DELISTED
CBL& Associates Properties, Inc.
CBL
$2.46M 0.05%
+129,023
New +$2.72M
CCL icon
222
Carnival Corporation Ltd
CCL
$39.4B
$2.45M 0.05%
+75,000
New +$2.72M
GCVRZ
223
DELISTED
Sanofi Contingent Value Rights
GCVRZ
$2.43M 0.05%
1,203,178
-11,847
-1% -$22.6K
WCIC
224
DELISTED
WCI Communities, Inc.
WCIC
$2.42M 0.05%
+140,000
New +$2.27M
HTLD icon
225
Heartland Express
HTLD
$952M
$2.36M 0.05%
166,223
+113,693
+216% +$1.63M

Similar funds

UBS O'Connor's Q3 2013 Portfolio in Review

As of Q3 2013, UBS O'Connor held 673 positions worth $4.81B, down 9.9% from $5.34B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

UBS O'Connor withdrew a net $1.18B in Q3 2013, closing 256 positions and reducing 97 holdings. Its most notable exit was Pfizer, an estimated $167M position sold in full.

By sector, the portfolio is most concentrated in Real Estate at 15% of assets, up from 13% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.

Against the trend, UBS O'Connor opened a new position in Colgate-Palmolive worth $59.4M.

  • UBS O'Connor's largest Q3 2013 buy was Colgate-Palmolive: 1,002,498 shares worth $59.4M.
  • UBS O'Connor added most to ONYX PHARMACEUTICALS INC in Q3 2013, an estimated $56.3M increase.
  • UBS O'Connor's biggest Q3 2013 reduction was Advance Auto Parts, cutting an estimated $48.2M.
  • UBS O'Connor fully exited Pfizer in Q3 2013, selling an estimated $167M.
  • UBS O'Connor's ten largest holdings make up 18% of its $4.81B portfolio in Q3 2013.
  • UBS O'Connor opened 167 new positions and closed 256 in Q3 2013.
  • UBS O'Connor's portfolio value fell 9.9% quarter-over-quarter to $4.81B.

Based on UBS O'Connor's 13F filing for Q3 2013, filed 14 Nov 2013.